| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |